This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Dehydroepiandrosterone (DHEA) and aging (longevity)

Authoring team

  • adrenal glands secrete large amounts of the inactive precursor steroids dehydroepiandrosterone (DHEA) and its sulphate ester (DHEAS), which are converted into potent androgens and estrogens in peripheral tissue
    • secretion of DHEAS declines in humans with age
    • DHEAS is important in health maintenance; a myriad of studies in animals have suggested that DHEAS is a multifunctional hormone with immuno-enhancing, antidiabetic, antiobesity, anticancer, neurotrophic, memory-enhancing, and antiaging effects
    • serum DHEAS concentrations are higher in men than in women
    • maximal values of circulating DHEAS reach their peak between the ages of 20 and 30
      • after which serum DHEA and DHEAS levels decrease markedly
    • by the age of 70, serum DHEAS levels fall to approximately 20% of their peak values and decrease by 95% in people aged 85 to 90.
  • a 27-year study in a community-based cohort indicated that DHEAS level may be a predictor of longevity in men, independent of age, blood pressure, and plasma glucose
    • in men after adjustments for age, systolic blood pressure, and fasting plasma glucose showed significantly (log-rank stat =10.6; P<.001) greater longevity in the highest group (200 microg/dL) than in the moderate (130-199 microg/dL) or lowest groups (129 microg/dL)

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.